Immunosenescence and inflammaging are now regarded as central biological mechanisms of ageing. The age-related altered immune system is both weakened and chronically activated – with consequences for susceptibility to infection, tumor development and the large group of inflammation-driven cardiometabolic diseases. In the following, central molecular mechanisms, clinical manifestations and potential intervention approaches are summarized based on current reviews and primary studies on immunosenescence, chronic inflammation and age-associated diseases.
Autoren
- Tanja Schliebe
Publikation
- Longevity-Special
You May Also Like
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Cellular and Systemic Iron Homeostasis
“Steady State” – a delicately balanced equilibrium
- Psychedelic-assisted therapy
Current status of PAT
- First-line treatment for T2D